1,587
Views
13
CrossRef citations to date
0
Altmetric
Short Report

Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate

, , , , , , , , , , , & show all
Pages 3089-3096 | Received 14 Apr 2016, Accepted 06 Aug 2016, Published online: 28 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Victoria Ozberk, Manisha Pandey & Michael F. Good. (2018) Contribution of cryptic epitopes in designing a group A streptococcal vaccine. Human Vaccines & Immunotherapeutics 14:8, pages 2034-2052.
Read now

Articles from other publishers (12)

Victoria Ozberk, Mehfuz Zaman, Ailin Lepletier, Sharareh Eskandari, Jacqualine Kaden, Jamie-Lee Mills, Ainslie Calcutt, Jessica Dooley, Yongbao Huo, Emma L. Langshaw, Glen C. Ulett, Michael R. Batzloff, Michael F. Good & Manisha Pandey. (2023) A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils. Nature Communications 14:1.
Crossref
Simone Reynolds, Rukshan Ahamed Mohamed Rafeek, Adam Hamlin, Ailin Lepletier, Manisha Pandey, Natkunam Ketheesan & Michael F. Good. (2023) Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model. npj Vaccines 8:1.
Crossref
David J. McMillan, Rukshan A. M. Rafeek, Robert E. Norton, Michael F. Good, Kadaba S. Sriprakash & Natkunam Ketheesan. (2021) In Search of the Holy Grail: A Specific Diagnostic Test for Rheumatic Fever. Frontiers in Cardiovascular Medicine 8.
Crossref
Rukshan A. M. Rafeek, Suchandan Sikder, Adam S. Hamlin, Nicholas M. Andronicos, David J. McMillan, Kadaba S. Sriprakash & Natkunam Ketheesan. (2021) Requirements for a Robust Animal Model to Investigate the Disease Mechanism of Autoimmune Complications Associated With ARF/RHD. Frontiers in Cardiovascular Medicine 8.
Crossref
Leanne M. Dooley, Tarek B. Ahmad, Manisha Pandey, Michael F. Good & Michael Kotiw. (2021) Rheumatic heart disease: A review of the current status of global research activity. Autoimmunity Reviews 20:2, pages 102740.
Crossref
Simone Reynolds, Manisha Pandey, Jessica Dooley, Ainslie Calcutt, Michael Batzloff, Victoria Ozberk, Jamie-Lee Mills & Michael Good. (2021) Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines. Scientific Reports 11:1.
Crossref
Jamie-Lee S. Mills, Cesar M. Jayashi Flores, Simone Reynolds, Christine Wun, Ainslie Calcutt, S. Ben Baker, Senthil Murugappan, Alexandra C. I. Depelsenaire, Jessica Dooley, Paul V. Fahey, Angus H. Forster, Manisha Pandey & Michael F. Good. (2020) M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP). npj Vaccines 5:1.
Crossref
Patricia Therese Campbell, Hannah Frost, Pierre R. Smeesters, Joseph Kado, Michael F. Good, Michael Batzloff, Nicholas Geard, Jodie McVernon & Andrew Steer. (2018) Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8. Vaccine 36:50, pages 7618-7624.
Crossref
Chacko Jobichen, Ying Chong Tan, Mahalakshmi Tirumuru Prabhakar, Digant Nayak, Debabrata Biswas, Navraj S. Pannu, Emanuel Hanski & J. Sivaraman. (2018) Structure of ScpC, a virulence protease from Streptococcus pyogenes , reveals the functional domains and maturation mechanism . Biochemical Journal 475:17, pages 2847-2860.
Crossref
Silvana Sekuloski, Michael R. Batzloff, Paul Griffin, William Parsonage, Suzanne Elliott, Jon Hartas, Peter O’Rourke, Louise Marquart, Manisha Pandey, Fran A. Rubin, Jonathan Carapetis, James McCarthy & Michael F. Good. (2018) Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLOS ONE 13:7, pages e0198658.
Crossref
Manisha Pandey, Jessica Powell, Ainslie Calcutt, Mehfuz Zaman, Zachary N. Phillips, Mei Fong Ho, Michael R. Batzloff & Michael F. Good. (2017) Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial. Scientific Reports 7:1.
Crossref
Therése Nordström, Manisha Pandey, Ainslie Calcutt, Jessica Powell, Zachary N. Phillips, Grace Yeung, Ashwini K. Giddam, Yun Shi, Thomas Haselhorst, Mark von Itzstein, Michael R. Batzloff & Michael F. Good. (2017) Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen. The Journal of Immunology 199:8, pages 2794-2802.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.